|
|
幽门螺杆菌致病机制与抗体分型检测的研究
|
Abstract:
幽门螺杆菌是世界公认的I类致癌因子，也是全球最常见、最广泛的感染性病原体之一，其感染会引起慢性胃炎，并会增加患消化性溃疡、胃腺癌和胃黏膜相关淋巴组织淋巴瘤等疾病的风险，此外它还与多种胃肠外疾病密切相关。尽管在过去的几十年里，中国及全球的幽门螺旋杆菌感染率一直在持续下降，但近年来随着抗生素耐药性的上升，幽门螺杆菌根除治疗受到严峻挑战。本文就幽门螺杆菌致病机制及抗体分型检测的临床价值做一综述，从而为有针对性地选择幽门螺杆菌检测方法提供一定的临床参考依据。
Helicobacter pylori is a globally recognized Group I carcinogen and one of the most common and widespread infectious pathogens worldwide. Its infection can lead to chronic gastritis and elevate the risk of developing digestive ulcers, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Furthermore, it is closely linked to various extragastrointestinal diseases. Although the infection rate of Helicobacter pylori in China and globally has been continuously decreasing over the past few decades, the eradication treatment of Helicobacter pylori has been severely challenged in recent years due to the rise of antibiotic resistance. This article provides a review of the pathogenic mechanism of Helicobacter pylori and the clinical value of antibody typing detection, offering a clinical reference basis for targeted selection of Helicobacter pylori detection methods.
| [1] | Marshall, B. and Warren, J.R. (1984) Unidentified Curved Bacilli in the Stomach of Patients with Gastritis and Peptic Ulceration. The Lancet, 323, 1311-1315. https://doi.org/10.1016/s0140-6736(84)91816-6 |
| [2] | Leja, M., Grinberga‐Derica, I., Bilgilier, C. and Steininger, C. (2019) Review: Epidemiology of helicobacter pylori Infection. Helicobacter, 24, e12635. https://doi.org/10.1111/hel.12635 |
| [3] | Chen, Y., Malfertheiner, P., Yu, H., Kuo, C., Chang, Y., Meng, F., et al. (2024) Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer between 1980 and 2022. Gastroenterology, 166, 605-619. https://doi.org/10.1053/j.gastro.2023.12.022 |
| [4] | Ren, S., Cai, P., Liu, Y., Wang, T., Zhang, Y., Li, Q., et al. (2021) Prevalence of Helicobacter pylori Infection in China: A Systematic Review and Meta‐analysis. Journal of Gastroenterology and Hepatology, 37, 464-470. https://doi.org/10.1111/jgh.15751 |
| [5] | Sun, Y. and Zhang, J. (2019) Helicobacter pylori Recrudescence and Its Influencing Factors. Journal of Cellular and Molecular Medicine, 23, 7919-7925. https://doi.org/10.1111/jcmm.14682 |
| [6] | Burucoa, C. and Axon, A. (2017) Epidemiology of Helicobacter pylori Infection. Helicobacter, 22, e12403. https://doi.org/10.1111/hel.12403 |
| [7] | 杨舒, 张雷. 幽门螺旋杆菌致病与免疫机制的研究进展[J]. 中国病原生物学杂志, 2017, 12(3): 283-285, 289. |
| [8] | 罗微, 孙颖, 张晓方, 等. 幽门螺杆菌致病因子研究新进展[J]. 国际免疫学杂志, 2019, 42(4): 402-406. |
| [9] | Ansari, S. and Yamaoka, Y. (2019) Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and Its Pathogenicity. Toxins, 11, Article 677. https://doi.org/10.3390/toxins11110677 |
| [10] | Baj, J., Forma, A., Sitarz, M., Portincasa, P., Garruti, G., Krasowska, D., et al. (2020) Helicobacter pylori Virulence Factors—Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells, 10, Article 27. https://doi.org/10.3390/cells10010027 |
| [11] | Vital, J.S., Tanoeiro, L., Lopes-Oliveira, R. and Vale, F.F. (2022) Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data. Biomolecules, 12, Article 691. https://doi.org/10.3390/biom12050691 |
| [12] | Banga Ndzouboukou, J., Lei, Q., Ullah, N., Zhang, Y., Hao, L. and Fan, X. (2020) Helicobacter pylori Adhesins: HpaA a Potential Antigen in Experimental Vaccines for H. pylori. Helicobacter, 26, e12758. https://doi.org/10.1111/hel.12758 |
| [13] | FitzGerald, R. and Smith, S.M. (2021) An Overview of Helicobacter pylori Infection. In: Smith, S.M., Ed., Methods in Molecular Biology, Springer, 1-14. https://doi.org/10.1007/978-1-0716-1302-3_1 |
| [14] | Bakhti, S.Z., Latifi‐Navid, S. and Safaralizadeh, R. (2020) Helicobacter pylori‐Related Risk Predictors of Gastric Cancer: The Latest Models, Challenges, and Future Prospects. Cancer Medicine, 9, 4808-4822. https://doi.org/10.1002/cam4.3068 |
| [15] | Cover, T.L., Lacy, D.B. and Ohi, M.D. (2020) The Helicobacter pylori Cag Type IV Secretion System. Trends in Microbiology, 28, 682-695. https://doi.org/10.1016/j.tim.2020.02.004 |
| [16] | Knorr, J., Ricci, V., Hatakeyama, M. and Backert, S. (2019) Classification of Helicobacter pylori Virulence Factors: Is Caga a Toxin or Not? Trends in Microbiology, 27, 731-738. https://doi.org/10.1016/j.tim.2019.04.010 |
| [17] | Săsăran, M.O., Meliț, L.E. and Dobru, E.D. (2021) Microrna Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori. International Journal of Molecular Sciences, 22, Article 1406. https://doi.org/10.3390/ijms22031406 |
| [18] | Salvatori, S., Marafini, I., Laudisi, F., Monteleone, G. and Stolfi, C. (2023) Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. International Journal of Molecular Sciences, 24, Article 2895. https://doi.org/10.3390/ijms24032895 |
| [19] | 马小莉, 包志贤, 袁浩, 等. 幽门螺杆菌感染的免疫应答及免疫逃逸机制研究进展[J]. 生命科学研究, 2023, 27(2): 147-154, 188. |
| [20] | 曹国君, 李生梅, 关明. 幽门螺旋杆菌检测方法的选择及其实验室诊断路径[J]. 中华检验医学杂志, 2016, 39(11): 864-867. |
| [21] | 贠建蔚, 齐国卿, 张德奎. 幽门螺杆菌分型的研究现状[J]. 中华传染病杂志, 2021, 39(4): 243-247. |
| [22] | 周冷潇, 张卿, 高鹰. 幽门螺杆菌抗体分型检测的研究进展[J]. 中华健康管理学杂志, 2019, 13(4): 354-357. |
| [23] | 方莉萍, 冯胜春, 朱亦璇, 等. 金华地区幽门螺旋杆菌感染情况及抗体分型分析[J]. 中国卫生检验杂志, 2022, 32(23): 2870-2872. |
| [24] | 彭钧, 李小月, 王万俊, 等. 安徽省安庆地区健康体检人群幽门螺旋杆菌感染调查及免疫学分型研究[J]. 现代检验医学杂志, 2021, 36(1): 18-21. |
